Paxman AB (PXMBF)
Paxman AB is a healthcare equipment company listed on OTC Markets as common stock. Through its subsidiaries, the company develops and sells the Paxman scalp cooling system, which is designed to help reduce hair loss during chemotherapy treatment. Its products are used by cancer centers and hospitals in markets around the world. Paxman has also worked with the University of Huddersfield, the University of Leeds, and the National University Hospital of Singapore on related cooling technologies, including a wearable medical cooling device and a cooling and compression system. Founded in 1996, Paxman AB is headquartered in Karlshamn, Sweden.
Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ
Jump directly to the stock analysis sections supported by the latest available data.
Data update note:
Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Overall Financial Health | Dividend Yield | Next Earnings Date | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
OTC-PXMB.F
|
$4.76
|
36.0% Upside
|
Undervalued
|
Not available
|
Not available
|
Good
|
0.0%
|
November 20, 2026
|
3.3x
|
3.8x
|
141.5 M
|
133.9 M
|
0.8%
|
71.4%
|
13.5
|
398.7%
|
